nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—stomach cancer—pancreatic cancer	0.302	1	CtDrD
Floxuridine—TYMP—pancreatic cancer	0.199	0.68	CbGaD
Floxuridine—Decitabine—Gemcitabine—pancreatic cancer	0.109	1	CrCrCtD
Floxuridine—TYMP—Fluorouracil—pancreatic cancer	0.103	0.464	CbGbCtD
Floxuridine—TYMS—pancreatic cancer	0.0937	0.32	CbGaD
Floxuridine—TYMS—Gemcitabine—pancreatic cancer	0.064	0.289	CbGbCtD
Floxuridine—TYMS—Fluorouracil—pancreatic cancer	0.0547	0.247	CbGbCtD
Floxuridine—TYMP—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00235	0.111	CbGpPWpGaD
Floxuridine—TYMP—Pyrimidine catabolism—DPYD—pancreatic cancer	0.0021	0.0996	CbGpPWpGaD
Floxuridine—TYMP—Pyrimidine metabolism—DPYD—pancreatic cancer	0.00121	0.0572	CbGpPWpGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.0012	0.057	CbGpPWpGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000934	0.0443	CbGpPWpGaD
Floxuridine—TYMS—Pyrimidine metabolism—TYMP—pancreatic cancer	0.000778	0.0369	CbGpPWpGaD
Floxuridine—Trifluridine—TYMP—pancreatic cancer	0.000701	0.462	CrCbGaD
Floxuridine—TYMP—Pyrimidine metabolism—TYMS—pancreatic cancer	0.000687	0.0326	CbGpPWpGaD
Floxuridine—TYMS—Pyrimidine metabolism—DPYD—pancreatic cancer	0.000617	0.0293	CbGpPWpGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000603	0.0286	CbGpPWpGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000532	0.0253	CbGpPWpGaD
Floxuridine—Zidovudine—TERT—pancreatic cancer	0.000486	0.32	CrCbGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000478	0.0227	CbGpPWpGaD
Floxuridine—TYMS—Paclitaxel—Docetaxel—pancreatic cancer	0.000475	0.451	CbGdCrCtD
Floxuridine—TYMP—Nucleotide metabolism—DPYD—pancreatic cancer	0.000469	0.0223	CbGpPWpGaD
Floxuridine—TYMS—Gefitinib—Erlotinib—pancreatic cancer	0.000456	0.433	CbGdCrCtD
Floxuridine—TYMP—Bladder Cancer—EGF—pancreatic cancer	0.000406	0.0193	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—RBBP8—pancreatic cancer	0.000399	0.019	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—RB1—pancreatic cancer	0.000379	0.018	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CDH1—pancreatic cancer	0.000378	0.0179	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CDKN2A—pancreatic cancer	0.000334	0.0158	CbGpPWpGaD
Floxuridine—Trifluridine—TYMS—pancreatic cancer	0.000329	0.217	CrCbGaD
Floxuridine—TYMS—Nucleotide metabolism—TYMP—pancreatic cancer	0.000303	0.0144	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CXCL8—pancreatic cancer	0.000302	0.0144	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CCND1—pancreatic cancer	0.000282	0.0134	CbGpPWpGaD
Floxuridine—TYMP—Nucleotide metabolism—TYMS—pancreatic cancer	0.000268	0.0127	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—VEGFA—pancreatic cancer	0.000246	0.0117	CbGpPWpGaD
Floxuridine—TYMS—Nucleotide metabolism—DPYD—pancreatic cancer	0.00024	0.0114	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000233	0.0111	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—MYC—pancreatic cancer	0.000226	0.0107	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—EGFR—pancreatic cancer	0.000221	0.0105	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—TP53—pancreatic cancer	0.000186	0.00881	CbGpPWpGaD
Floxuridine—TYMS—E2F mediated regulation of DNA replication—RB1—pancreatic cancer	0.000185	0.00876	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—HRAS—pancreatic cancer	0.000178	0.00843	CbGpPWpGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000177	0.00838	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000169	0.00803	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—SYCP1—pancreatic cancer	0.000156	0.00743	CbGpPWpGaD
Floxuridine—TYMS—Azacitidine—Gemcitabine—pancreatic cancer	0.000123	0.117	CbGdCrCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000119	0.00566	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—PLAU—pancreatic cancer	0.000119	0.00565	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—AHR—pancreatic cancer	0.000117	0.00558	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000107	0.00508	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000106	0.00501	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—RB1—pancreatic cancer	9.78e-05	0.00464	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	9.23e-05	0.00438	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	9.07e-05	0.00431	CbGpPWpGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—TP53—pancreatic cancer	9.03e-05	0.00429	CbGpPWpGaD
Floxuridine—Muscle spasms—Sunitinib—pancreatic cancer	8.93e-05	0.00176	CcSEcCtD
Floxuridine—Agranulocytosis—Gemcitabine—pancreatic cancer	8.9e-05	0.00175	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—EZH2—pancreatic cancer	8.86e-05	0.00421	CbGpPWpGaD
Floxuridine—Glossitis—Epirubicin—pancreatic cancer	8.85e-05	0.00174	CcSEcCtD
Floxuridine—Lacrimation increased—Epirubicin—pancreatic cancer	8.85e-05	0.00174	CcSEcCtD
Floxuridine—Epistaxis—Fluorouracil—pancreatic cancer	8.84e-05	0.00174	CcSEcCtD
Floxuridine—Haemoglobin—Irinotecan—pancreatic cancer	8.83e-05	0.00174	CcSEcCtD
Floxuridine—Infection—Tamoxifen—pancreatic cancer	8.79e-05	0.00173	CcSEcCtD
Floxuridine—Haemorrhage—Irinotecan—pancreatic cancer	8.79e-05	0.00173	CcSEcCtD
Floxuridine—Agranulocytosis—Fluorouracil—pancreatic cancer	8.75e-05	0.00172	CcSEcCtD
Floxuridine—Infection—Erlotinib—pancreatic cancer	8.7e-05	0.00171	CcSEcCtD
Floxuridine—Thrombocytopenia—Tamoxifen—pancreatic cancer	8.66e-05	0.00171	CcSEcCtD
Floxuridine—Haemoglobin—Gemcitabine—pancreatic cancer	8.6e-05	0.00169	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—CDKN2A—pancreatic cancer	8.6e-05	0.00408	CbGpPWpGaD
Floxuridine—Nervous system disorder—Erlotinib—pancreatic cancer	8.58e-05	0.00169	CcSEcCtD
Floxuridine—Anaemia—Sunitinib—pancreatic cancer	8.58e-05	0.00169	CcSEcCtD
Floxuridine—Thrombocytopenia—Erlotinib—pancreatic cancer	8.57e-05	0.00169	CcSEcCtD
Floxuridine—Haemorrhage—Gemcitabine—pancreatic cancer	8.56e-05	0.00168	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	8.5e-05	0.00404	CbGpPWpGaD
Floxuridine—Pharyngitis—Gemcitabine—pancreatic cancer	8.49e-05	0.00167	CcSEcCtD
Floxuridine—Haemoglobin—Fluorouracil—pancreatic cancer	8.46e-05	0.00166	CcSEcCtD
Floxuridine—Anorexia—Tamoxifen—pancreatic cancer	8.43e-05	0.00166	CcSEcCtD
Floxuridine—Haemorrhage—Fluorouracil—pancreatic cancer	8.42e-05	0.00166	CcSEcCtD
Floxuridine—Pharyngitis—Fluorouracil—pancreatic cancer	8.35e-05	0.00164	CcSEcCtD
Floxuridine—Anorexia—Erlotinib—pancreatic cancer	8.34e-05	0.00164	CcSEcCtD
Floxuridine—Leukopenia—Sunitinib—pancreatic cancer	8.31e-05	0.00164	CcSEcCtD
Floxuridine—Glossitis—Doxorubicin—pancreatic cancer	8.19e-05	0.00161	CcSEcCtD
Floxuridine—Lacrimation increased—Doxorubicin—pancreatic cancer	8.19e-05	0.00161	CcSEcCtD
Floxuridine—Dry skin—Docetaxel—pancreatic cancer	8.05e-05	0.00158	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—RBBP8—pancreatic cancer	8.01e-05	0.0038	CbGpPWpGaD
Floxuridine—Cramp muscle—Docetaxel—pancreatic cancer	7.91e-05	0.00156	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	7.77e-05	0.00369	CbGpPWpGaD
Floxuridine—Alopecia—Irinotecan—pancreatic cancer	7.76e-05	0.00153	CcSEcCtD
Floxuridine—Decreased appetite—Tamoxifen—pancreatic cancer	7.69e-05	0.00151	CcSEcCtD
Floxuridine—Decreased appetite—Erlotinib—pancreatic cancer	7.61e-05	0.0015	CcSEcCtD
Floxuridine—Alopecia—Gemcitabine—pancreatic cancer	7.56e-05	0.00149	CcSEcCtD
Floxuridine—Infection—Sunitinib—pancreatic cancer	7.53e-05	0.00148	CcSEcCtD
Floxuridine—Erythema—Gemcitabine—pancreatic cancer	7.45e-05	0.00147	CcSEcCtD
Floxuridine—Alopecia—Fluorouracil—pancreatic cancer	7.44e-05	0.00146	CcSEcCtD
Floxuridine—Nervous system disorder—Sunitinib—pancreatic cancer	7.43e-05	0.00146	CcSEcCtD
Floxuridine—Thrombocytopenia—Sunitinib—pancreatic cancer	7.42e-05	0.00146	CcSEcCtD
Floxuridine—Rash maculo-papular—Epirubicin—pancreatic cancer	7.41e-05	0.00146	CcSEcCtD
Floxuridine—Angina pectoris—Docetaxel—pancreatic cancer	7.39e-05	0.00145	CcSEcCtD
Floxuridine—Muscle spasms—Irinotecan—pancreatic cancer	7.35e-05	0.00145	CcSEcCtD
Floxuridine—Erythema—Fluorouracil—pancreatic cancer	7.33e-05	0.00144	CcSEcCtD
Floxuridine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	7.24e-05	0.00142	CcSEcCtD
Floxuridine—Anorexia—Sunitinib—pancreatic cancer	7.22e-05	0.00142	CcSEcCtD
Floxuridine—Pancytopenia—Docetaxel—pancreatic cancer	7.21e-05	0.00142	CcSEcCtD
Floxuridine—Gastrointestinal pain—Erlotinib—pancreatic cancer	7.16e-05	0.00141	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—RB1—pancreatic cancer	7.1e-05	0.00337	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Irinotecan—pancreatic cancer	7.1e-05	0.0014	CcSEcCtD
Floxuridine—TYMP—Metabolism—PRSS1—pancreatic cancer	7.1e-05	0.00337	CbGpPWpGaD
Floxuridine—Anaemia—Irinotecan—pancreatic cancer	7.07e-05	0.00139	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	7.03e-05	0.00334	CbGpPWpGaD
Floxuridine—Abdominal pain—Tamoxifen—pancreatic cancer	6.99e-05	0.00138	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	6.97e-05	0.00331	CbGpPWpGaD
Floxuridine—Body temperature increased—Erlotinib—pancreatic cancer	6.92e-05	0.00136	CcSEcCtD
Floxuridine—Abdominal pain—Erlotinib—pancreatic cancer	6.92e-05	0.00136	CcSEcCtD
Floxuridine—Ill-defined disorder—Gemcitabine—pancreatic cancer	6.91e-05	0.00136	CcSEcCtD
Floxuridine—Malaise—Irinotecan—pancreatic cancer	6.9e-05	0.00136	CcSEcCtD
Floxuridine—Anaemia—Gemcitabine—pancreatic cancer	6.89e-05	0.00136	CcSEcCtD
Floxuridine—Rash maculo-papular—Doxorubicin—pancreatic cancer	6.86e-05	0.00135	CcSEcCtD
Floxuridine—Leukopenia—Irinotecan—pancreatic cancer	6.85e-05	0.00135	CcSEcCtD
Floxuridine—Thrombophlebitis—Epirubicin—pancreatic cancer	6.84e-05	0.00135	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	6.81e-05	0.00323	CbGpPWpGaD
Floxuridine—Anaemia—Fluorouracil—pancreatic cancer	6.77e-05	0.00133	CcSEcCtD
Floxuridine—Photosensitivity—Epirubicin—pancreatic cancer	6.74e-05	0.00133	CcSEcCtD
Floxuridine—Malaise—Gemcitabine—pancreatic cancer	6.72e-05	0.00132	CcSEcCtD
Floxuridine—Leukopenia—Gemcitabine—pancreatic cancer	6.67e-05	0.00131	CcSEcCtD
Floxuridine—Stomatitis—Docetaxel—pancreatic cancer	6.59e-05	0.0013	CcSEcCtD
Floxuridine—Decreased appetite—Sunitinib—pancreatic cancer	6.59e-05	0.0013	CcSEcCtD
Floxuridine—Leukopenia—Fluorouracil—pancreatic cancer	6.56e-05	0.00129	CcSEcCtD
Floxuridine—Hypersensitivity—Tamoxifen—pancreatic cancer	6.52e-05	0.00128	CcSEcCtD
Floxuridine—Discomfort—Irinotecan—pancreatic cancer	6.43e-05	0.00127	CcSEcCtD
Floxuridine—Epistaxis—Docetaxel—pancreatic cancer	6.38e-05	0.00126	CcSEcCtD
Floxuridine—Asthenia—Tamoxifen—pancreatic cancer	6.35e-05	0.00125	CcSEcCtD
Floxuridine—Thrombophlebitis—Doxorubicin—pancreatic cancer	6.33e-05	0.00125	CcSEcCtD
Floxuridine—Agranulocytosis—Docetaxel—pancreatic cancer	6.31e-05	0.00124	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	6.31e-05	0.003	CbGpPWpGaD
Floxuridine—Confusional state—Irinotecan—pancreatic cancer	6.29e-05	0.00124	CcSEcCtD
Floxuridine—Asthenia—Erlotinib—pancreatic cancer	6.28e-05	0.00124	CcSEcCtD
Floxuridine—Discomfort—Gemcitabine—pancreatic cancer	6.27e-05	0.00123	CcSEcCtD
Floxuridine—Anaphylactic shock—Irinotecan—pancreatic cancer	6.24e-05	0.00123	CcSEcCtD
Floxuridine—Photosensitivity—Doxorubicin—pancreatic cancer	6.24e-05	0.00123	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—PPP2R5B—pancreatic cancer	6.23e-05	0.00296	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	6.21e-05	0.00295	CbGpPWpGaD
Floxuridine—Infection—Irinotecan—pancreatic cancer	6.2e-05	0.00122	CcSEcCtD
Floxuridine—Gastrointestinal pain—Sunitinib—pancreatic cancer	6.2e-05	0.00122	CcSEcCtD
Floxuridine—Discomfort—Fluorouracil—pancreatic cancer	6.16e-05	0.00121	CcSEcCtD
Floxuridine—TYMP—Metabolism—ARG2—pancreatic cancer	6.15e-05	0.00292	CbGpPWpGaD
Floxuridine—Nervous system disorder—Irinotecan—pancreatic cancer	6.12e-05	0.0012	CcSEcCtD
Floxuridine—Thrombocytopenia—Irinotecan—pancreatic cancer	6.11e-05	0.0012	CcSEcCtD
Floxuridine—Haemoglobin—Docetaxel—pancreatic cancer	6.1e-05	0.0012	CcSEcCtD
Floxuridine—Anaphylactic shock—Gemcitabine—pancreatic cancer	6.08e-05	0.0012	CcSEcCtD
Floxuridine—Haemorrhage—Docetaxel—pancreatic cancer	6.07e-05	0.0012	CcSEcCtD
Floxuridine—Diarrhoea—Tamoxifen—pancreatic cancer	6.05e-05	0.00119	CcSEcCtD
Floxuridine—Lethargy—Epirubicin—pancreatic cancer	6.04e-05	0.00119	CcSEcCtD
Floxuridine—Infection—Gemcitabine—pancreatic cancer	6.04e-05	0.00119	CcSEcCtD
Floxuridine—Confusional state—Fluorouracil—pancreatic cancer	6.03e-05	0.00119	CcSEcCtD
Floxuridine—Pharyngitis—Docetaxel—pancreatic cancer	6.03e-05	0.00119	CcSEcCtD
Floxuridine—Abdominal pain—Sunitinib—pancreatic cancer	5.99e-05	0.00118	CcSEcCtD
Floxuridine—Body temperature increased—Sunitinib—pancreatic cancer	5.99e-05	0.00118	CcSEcCtD
Floxuridine—Diarrhoea—Erlotinib—pancreatic cancer	5.99e-05	0.00118	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—RB1—pancreatic cancer	5.98e-05	0.00284	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Fluorouracil—pancreatic cancer	5.98e-05	0.00118	CcSEcCtD
Floxuridine—Nervous system disorder—Gemcitabine—pancreatic cancer	5.96e-05	0.00117	CcSEcCtD
Floxuridine—Thrombocytopenia—Gemcitabine—pancreatic cancer	5.95e-05	0.00117	CcSEcCtD
Floxuridine—Anorexia—Irinotecan—pancreatic cancer	5.95e-05	0.00117	CcSEcCtD
Floxuridine—Infection—Fluorouracil—pancreatic cancer	5.94e-05	0.00117	CcSEcCtD
Floxuridine—Nervous system disorder—Fluorouracil—pancreatic cancer	5.86e-05	0.00115	CcSEcCtD
Floxuridine—Thrombocytopenia—Fluorouracil—pancreatic cancer	5.85e-05	0.00115	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—MYC—pancreatic cancer	5.83e-05	0.00277	CbGpPWpGaD
Floxuridine—Anorexia—Gemcitabine—pancreatic cancer	5.8e-05	0.00114	CcSEcCtD
Floxuridine—Anorexia—Fluorouracil—pancreatic cancer	5.7e-05	0.00112	CcSEcCtD
Floxuridine—Vomiting—Tamoxifen—pancreatic cancer	5.63e-05	0.00111	CcSEcCtD
Floxuridine—Lethargy—Doxorubicin—pancreatic cancer	5.59e-05	0.0011	CcSEcCtD
Floxuridine—Hypersensitivity—Sunitinib—pancreatic cancer	5.58e-05	0.0011	CcSEcCtD
Floxuridine—Rash—Tamoxifen—pancreatic cancer	5.58e-05	0.0011	CcSEcCtD
Floxuridine—Dermatitis—Tamoxifen—pancreatic cancer	5.57e-05	0.0011	CcSEcCtD
Floxuridine—Vomiting—Erlotinib—pancreatic cancer	5.57e-05	0.0011	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—FOXM1—pancreatic cancer	5.55e-05	0.00264	CbGpPWpGaD
Floxuridine—Headache—Tamoxifen—pancreatic cancer	5.54e-05	0.00109	CcSEcCtD
Floxuridine—Rash—Erlotinib—pancreatic cancer	5.52e-05	0.00109	CcSEcCtD
Floxuridine—Dermatitis—Erlotinib—pancreatic cancer	5.51e-05	0.00109	CcSEcCtD
Floxuridine—Headache—Erlotinib—pancreatic cancer	5.48e-05	0.00108	CcSEcCtD
Floxuridine—Asthenia—Sunitinib—pancreatic cancer	5.44e-05	0.00107	CcSEcCtD
Floxuridine—Dry skin—Epirubicin—pancreatic cancer	5.43e-05	0.00107	CcSEcCtD
Floxuridine—Decreased appetite—Irinotecan—pancreatic cancer	5.43e-05	0.00107	CcSEcCtD
Floxuridine—Alopecia—Docetaxel—pancreatic cancer	5.37e-05	0.00106	CcSEcCtD
Floxuridine—Erythema—Docetaxel—pancreatic cancer	5.29e-05	0.00104	CcSEcCtD
Floxuridine—Decreased appetite—Gemcitabine—pancreatic cancer	5.29e-05	0.00104	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	5.26e-05	0.0025	CbGpPWpGaD
Floxuridine—Nausea—Tamoxifen—pancreatic cancer	5.26e-05	0.00103	CcSEcCtD
Floxuridine—Gastritis—Epirubicin—pancreatic cancer	5.24e-05	0.00103	CcSEcCtD
Floxuridine—Nausea—Erlotinib—pancreatic cancer	5.2e-05	0.00102	CcSEcCtD
Floxuridine—Decreased appetite—Fluorouracil—pancreatic cancer	5.2e-05	0.00102	CcSEcCtD
Floxuridine—Diarrhoea—Sunitinib—pancreatic cancer	5.19e-05	0.00102	CcSEcCtD
Floxuridine—Feeling abnormal—Irinotecan—pancreatic cancer	5.14e-05	0.00101	CcSEcCtD
Floxuridine—Gastrointestinal pain—Irinotecan—pancreatic cancer	5.1e-05	0.001	CcSEcCtD
Floxuridine—Muscle spasms—Docetaxel—pancreatic cancer	5.08e-05	0.001	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	5.07e-05	0.0024	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	5.06e-05	0.0024	CbGpPWpGaD
Floxuridine—Dry skin—Doxorubicin—pancreatic cancer	5.02e-05	0.000988	CcSEcCtD
Floxuridine—Feeling abnormal—Gemcitabine—pancreatic cancer	5.01e-05	0.000986	CcSEcCtD
Floxuridine—Angina pectoris—Epirubicin—pancreatic cancer	4.99e-05	0.000981	CcSEcCtD
Floxuridine—Abdominal pain—Irinotecan—pancreatic cancer	4.93e-05	0.000971	CcSEcCtD
Floxuridine—Body temperature increased—Irinotecan—pancreatic cancer	4.93e-05	0.000971	CcSEcCtD
Floxuridine—Feeling abnormal—Fluorouracil—pancreatic cancer	4.93e-05	0.00097	CcSEcCtD
Floxuridine—Anaemia—Docetaxel—pancreatic cancer	4.89e-05	0.000962	CcSEcCtD
Floxuridine—Pancytopenia—Epirubicin—pancreatic cancer	4.86e-05	0.000957	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	4.85e-05	0.0023	CbGpPWpGaD
Floxuridine—Gastritis—Doxorubicin—pancreatic cancer	4.85e-05	0.000954	CcSEcCtD
Floxuridine—Vomiting—Sunitinib—pancreatic cancer	4.82e-05	0.000948	CcSEcCtD
Floxuridine—Body temperature increased—Gemcitabine—pancreatic cancer	4.81e-05	0.000946	CcSEcCtD
Floxuridine—Rash—Sunitinib—pancreatic cancer	4.78e-05	0.00094	CcSEcCtD
Floxuridine—Dermatitis—Sunitinib—pancreatic cancer	4.77e-05	0.00094	CcSEcCtD
Floxuridine—Headache—Sunitinib—pancreatic cancer	4.75e-05	0.000934	CcSEcCtD
Floxuridine—Leukopenia—Docetaxel—pancreatic cancer	4.73e-05	0.000931	CcSEcCtD
Floxuridine—Body temperature increased—Fluorouracil—pancreatic cancer	4.73e-05	0.00093	CcSEcCtD
Floxuridine—Photosensitivity reaction—Epirubicin—pancreatic cancer	4.67e-05	0.000919	CcSEcCtD
Floxuridine—Angina pectoris—Doxorubicin—pancreatic cancer	4.61e-05	0.000908	CcSEcCtD
Floxuridine—Hypersensitivity—Irinotecan—pancreatic cancer	4.6e-05	0.000905	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—PPARG—pancreatic cancer	4.55e-05	0.00216	CbGpPWpGaD
Floxuridine—Nausea—Sunitinib—pancreatic cancer	4.5e-05	0.000886	CcSEcCtD
Floxuridine—Pancytopenia—Doxorubicin—pancreatic cancer	4.5e-05	0.000885	CcSEcCtD
Floxuridine—Asthenia—Irinotecan—pancreatic cancer	4.48e-05	0.000881	CcSEcCtD
Floxuridine—Stomatitis—Epirubicin—pancreatic cancer	4.45e-05	0.000875	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	4.44e-05	0.00211	CbGpPWpGaD
Floxuridine—Hypersensitivity—Fluorouracil—pancreatic cancer	4.4e-05	0.000867	CcSEcCtD
Floxuridine—Asthenia—Gemcitabine—pancreatic cancer	4.36e-05	0.000859	CcSEcCtD
Floxuridine—Confusional state—Docetaxel—pancreatic cancer	4.35e-05	0.000856	CcSEcCtD
Floxuridine—TYMP—Metabolism—GLP1R—pancreatic cancer	4.33e-05	0.00206	CbGpPWpGaD
Floxuridine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	4.32e-05	0.000851	CcSEcCtD
Floxuridine—Anaphylactic shock—Docetaxel—pancreatic cancer	4.32e-05	0.000849	CcSEcCtD
Floxuridine—Epistaxis—Epirubicin—pancreatic cancer	4.3e-05	0.000847	CcSEcCtD
Floxuridine—Infection—Docetaxel—pancreatic cancer	4.29e-05	0.000844	CcSEcCtD
Floxuridine—Diarrhoea—Irinotecan—pancreatic cancer	4.27e-05	0.000841	CcSEcCtD
Floxuridine—TYMP—Metabolism—DPYD—pancreatic cancer	4.26e-05	0.00202	CbGpPWpGaD
Floxuridine—Agranulocytosis—Epirubicin—pancreatic cancer	4.26e-05	0.000838	CcSEcCtD
Floxuridine—Nervous system disorder—Docetaxel—pancreatic cancer	4.23e-05	0.000833	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—MYC—pancreatic cancer	4.23e-05	0.00201	CbGpPWpGaD
Floxuridine—Thrombocytopenia—Docetaxel—pancreatic cancer	4.22e-05	0.000832	CcSEcCtD
Floxuridine—Diarrhoea—Gemcitabine—pancreatic cancer	4.16e-05	0.000819	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	4.16e-05	0.00197	CbGpPWpGaD
Floxuridine—Haemoglobin—Epirubicin—pancreatic cancer	4.12e-05	0.00081	CcSEcCtD
Floxuridine—Stomatitis—Doxorubicin—pancreatic cancer	4.12e-05	0.00081	CcSEcCtD
Floxuridine—Anorexia—Docetaxel—pancreatic cancer	4.11e-05	0.00081	CcSEcCtD
Floxuridine—Haemorrhage—Epirubicin—pancreatic cancer	4.1e-05	0.000806	CcSEcCtD
Floxuridine—Diarrhoea—Fluorouracil—pancreatic cancer	4.09e-05	0.000805	CcSEcCtD
Floxuridine—Pharyngitis—Epirubicin—pancreatic cancer	4.07e-05	0.0008	CcSEcCtD
Floxuridine—TYMP—Metabolism—SLC2A2—pancreatic cancer	4.05e-05	0.00192	CbGpPWpGaD
Floxuridine—Epistaxis—Doxorubicin—pancreatic cancer	3.98e-05	0.000784	CcSEcCtD
Floxuridine—Vomiting—Irinotecan—pancreatic cancer	3.97e-05	0.000781	CcSEcCtD
Floxuridine—Agranulocytosis—Doxorubicin—pancreatic cancer	3.94e-05	0.000776	CcSEcCtD
Floxuridine—Rash—Irinotecan—pancreatic cancer	3.94e-05	0.000775	CcSEcCtD
Floxuridine—Dermatitis—Irinotecan—pancreatic cancer	3.93e-05	0.000774	CcSEcCtD
Floxuridine—Headache—Irinotecan—pancreatic cancer	3.91e-05	0.00077	CcSEcCtD
Floxuridine—Vomiting—Gemcitabine—pancreatic cancer	3.87e-05	0.000761	CcSEcCtD
Floxuridine—Rash—Gemcitabine—pancreatic cancer	3.83e-05	0.000755	CcSEcCtD
Floxuridine—Dermatitis—Gemcitabine—pancreatic cancer	3.83e-05	0.000754	CcSEcCtD
Floxuridine—Haemoglobin—Doxorubicin—pancreatic cancer	3.81e-05	0.00075	CcSEcCtD
Floxuridine—Headache—Gemcitabine—pancreatic cancer	3.81e-05	0.00075	CcSEcCtD
Floxuridine—Vomiting—Fluorouracil—pancreatic cancer	3.8e-05	0.000748	CcSEcCtD
Floxuridine—Haemorrhage—Doxorubicin—pancreatic cancer	3.79e-05	0.000746	CcSEcCtD
Floxuridine—Rash—Fluorouracil—pancreatic cancer	3.77e-05	0.000742	CcSEcCtD
Floxuridine—Dermatitis—Fluorouracil—pancreatic cancer	3.77e-05	0.000741	CcSEcCtD
Floxuridine—Pharyngitis—Doxorubicin—pancreatic cancer	3.76e-05	0.00074	CcSEcCtD
Floxuridine—Decreased appetite—Docetaxel—pancreatic cancer	3.75e-05	0.000738	CcSEcCtD
Floxuridine—Headache—Fluorouracil—pancreatic cancer	3.75e-05	0.000737	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	3.73e-05	0.00177	CbGpPWpGaD
Floxuridine—Nausea—Irinotecan—pancreatic cancer	3.71e-05	0.00073	CcSEcCtD
Floxuridine—TYMS—Metabolism—PRSS1—pancreatic cancer	3.63e-05	0.00172	CbGpPWpGaD
Floxuridine—Alopecia—Epirubicin—pancreatic cancer	3.62e-05	0.000713	CcSEcCtD
Floxuridine—Nausea—Gemcitabine—pancreatic cancer	3.61e-05	0.000711	CcSEcCtD
Floxuridine—Erythema—Epirubicin—pancreatic cancer	3.57e-05	0.000702	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—MYC—pancreatic cancer	3.56e-05	0.00169	CbGpPWpGaD
Floxuridine—Feeling abnormal—Docetaxel—pancreatic cancer	3.56e-05	0.0007	CcSEcCtD
Floxuridine—Nausea—Fluorouracil—pancreatic cancer	3.55e-05	0.000699	CcSEcCtD
Floxuridine—Gastrointestinal pain—Docetaxel—pancreatic cancer	3.53e-05	0.000694	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	3.46e-05	0.00164	CbGpPWpGaD
Floxuridine—Muscle spasms—Epirubicin—pancreatic cancer	3.43e-05	0.000675	CcSEcCtD
Floxuridine—Abdominal pain—Docetaxel—pancreatic cancer	3.41e-05	0.000671	CcSEcCtD
Floxuridine—Body temperature increased—Docetaxel—pancreatic cancer	3.41e-05	0.000671	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.37e-05	0.0016	CbGpPWpGaD
Floxuridine—Alopecia—Doxorubicin—pancreatic cancer	3.35e-05	0.000659	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.33e-05	0.00158	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Epirubicin—pancreatic cancer	3.31e-05	0.000651	CcSEcCtD
Floxuridine—Erythema—Doxorubicin—pancreatic cancer	3.3e-05	0.000649	CcSEcCtD
Floxuridine—Anaemia—Epirubicin—pancreatic cancer	3.3e-05	0.000649	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3.25e-05	0.00154	CbGpPWpGaD
Floxuridine—Malaise—Epirubicin—pancreatic cancer	3.22e-05	0.000633	CcSEcCtD
Floxuridine—Leukopenia—Epirubicin—pancreatic cancer	3.19e-05	0.000628	CcSEcCtD
Floxuridine—Hypersensitivity—Docetaxel—pancreatic cancer	3.18e-05	0.000626	CcSEcCtD
Floxuridine—Muscle spasms—Doxorubicin—pancreatic cancer	3.17e-05	0.000624	CcSEcCtD
Floxuridine—TYMS—Metabolism—ARG2—pancreatic cancer	3.15e-05	0.00149	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CD44—pancreatic cancer	3.13e-05	0.00149	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—PTEN—pancreatic cancer	3.12e-05	0.00148	CbGpPWpGaD
Floxuridine—Asthenia—Docetaxel—pancreatic cancer	3.1e-05	0.000609	CcSEcCtD
Floxuridine—Ill-defined disorder—Doxorubicin—pancreatic cancer	3.06e-05	0.000603	CcSEcCtD
Floxuridine—Anaemia—Doxorubicin—pancreatic cancer	3.05e-05	0.0006	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—BRCA2—pancreatic cancer	3.04e-05	0.00144	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	3.01e-05	0.00143	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GCG—pancreatic cancer	3e-05	0.00143	CbGpPWpGaD
Floxuridine—Discomfort—Epirubicin—pancreatic cancer	3e-05	0.00059	CcSEcCtD
Floxuridine—Malaise—Doxorubicin—pancreatic cancer	2.98e-05	0.000586	CcSEcCtD
Floxuridine—Leukopenia—Doxorubicin—pancreatic cancer	2.95e-05	0.000581	CcSEcCtD
Floxuridine—Diarrhoea—Docetaxel—pancreatic cancer	2.95e-05	0.000581	CcSEcCtD
Floxuridine—Confusional state—Epirubicin—pancreatic cancer	2.93e-05	0.000578	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.93e-05	0.00139	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Epirubicin—pancreatic cancer	2.91e-05	0.000573	CcSEcCtD
Floxuridine—Infection—Epirubicin—pancreatic cancer	2.89e-05	0.000569	CcSEcCtD
Floxuridine—Nervous system disorder—Epirubicin—pancreatic cancer	2.85e-05	0.000562	CcSEcCtD
Floxuridine—Thrombocytopenia—Epirubicin—pancreatic cancer	2.85e-05	0.000561	CcSEcCtD
Floxuridine—TYMP—Metabolism—STK11—pancreatic cancer	2.82e-05	0.00134	CbGpPWpGaD
Floxuridine—Discomfort—Doxorubicin—pancreatic cancer	2.78e-05	0.000546	CcSEcCtD
Floxuridine—Anorexia—Epirubicin—pancreatic cancer	2.77e-05	0.000546	CcSEcCtD
Floxuridine—TYMS—Metabolism—TYMP—pancreatic cancer	2.75e-05	0.00131	CbGpPWpGaD
Floxuridine—Vomiting—Docetaxel—pancreatic cancer	2.74e-05	0.00054	CcSEcCtD
Floxuridine—Rash—Docetaxel—pancreatic cancer	2.72e-05	0.000535	CcSEcCtD
Floxuridine—Dermatitis—Docetaxel—pancreatic cancer	2.72e-05	0.000535	CcSEcCtD
Floxuridine—Confusional state—Doxorubicin—pancreatic cancer	2.72e-05	0.000534	CcSEcCtD
Floxuridine—Headache—Docetaxel—pancreatic cancer	2.7e-05	0.000532	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.7e-05	0.00128	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.69e-05	0.00128	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Doxorubicin—pancreatic cancer	2.69e-05	0.00053	CcSEcCtD
Floxuridine—Infection—Doxorubicin—pancreatic cancer	2.68e-05	0.000527	CcSEcCtD
Floxuridine—Nervous system disorder—Doxorubicin—pancreatic cancer	2.64e-05	0.00052	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.64e-05	0.00125	CbGpPWpGaD
Floxuridine—Thrombocytopenia—Doxorubicin—pancreatic cancer	2.64e-05	0.000519	CcSEcCtD
Floxuridine—Anorexia—Doxorubicin—pancreatic cancer	2.57e-05	0.000505	CcSEcCtD
Floxuridine—Nausea—Docetaxel—pancreatic cancer	2.56e-05	0.000504	CcSEcCtD
Floxuridine—Decreased appetite—Epirubicin—pancreatic cancer	2.53e-05	0.000498	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—TERT—pancreatic cancer	2.52e-05	0.0012	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.51e-05	0.00119	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.49e-05	0.00118	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—TYMS—pancreatic cancer	2.43e-05	0.00115	CbGpPWpGaD
Floxuridine—Feeling abnormal—Epirubicin—pancreatic cancer	2.4e-05	0.000472	CcSEcCtD
Floxuridine—Gastrointestinal pain—Epirubicin—pancreatic cancer	2.38e-05	0.000468	CcSEcCtD
Floxuridine—Decreased appetite—Doxorubicin—pancreatic cancer	2.34e-05	0.000461	CcSEcCtD
Floxuridine—Body temperature increased—Epirubicin—pancreatic cancer	2.3e-05	0.000453	CcSEcCtD
Floxuridine—Abdominal pain—Epirubicin—pancreatic cancer	2.3e-05	0.000453	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.29e-05	0.00109	CbGpPWpGaD
Floxuridine—Feeling abnormal—Doxorubicin—pancreatic cancer	2.22e-05	0.000437	CcSEcCtD
Floxuridine—TYMS—Metabolism—GLP1R—pancreatic cancer	2.22e-05	0.00105	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.22e-05	0.00105	CbGpPWpGaD
Floxuridine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	2.2e-05	0.000433	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—RB1—pancreatic cancer	2.19e-05	0.00104	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—DPYD—pancreatic cancer	2.18e-05	0.00104	CbGpPWpGaD
Floxuridine—Hypersensitivity—Epirubicin—pancreatic cancer	2.14e-05	0.000422	CcSEcCtD
Floxuridine—Abdominal pain—Doxorubicin—pancreatic cancer	2.13e-05	0.000419	CcSEcCtD
Floxuridine—Body temperature increased—Doxorubicin—pancreatic cancer	2.13e-05	0.000419	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—TP53—pancreatic cancer	2.13e-05	0.00101	CbGpPWpGaD
Floxuridine—Asthenia—Epirubicin—pancreatic cancer	2.09e-05	0.000411	CcSEcCtD
Floxuridine—TYMS—Metabolism—SLC2A2—pancreatic cancer	2.07e-05	0.000983	CbGpPWpGaD
Floxuridine—Diarrhoea—Epirubicin—pancreatic cancer	1.99e-05	0.000392	CcSEcCtD
Floxuridine—Hypersensitivity—Doxorubicin—pancreatic cancer	1.98e-05	0.000391	CcSEcCtD
Floxuridine—TYMP—Metabolism—APOE—pancreatic cancer	1.98e-05	0.000938	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—RB1—pancreatic cancer	1.96e-05	0.000931	CbGpPWpGaD
Floxuridine—Asthenia—Doxorubicin—pancreatic cancer	1.93e-05	0.00038	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	1.93e-05	0.000915	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.87e-05	0.000889	CbGpPWpGaD
Floxuridine—Vomiting—Epirubicin—pancreatic cancer	1.85e-05	0.000364	CcSEcCtD
Floxuridine—Diarrhoea—Doxorubicin—pancreatic cancer	1.84e-05	0.000363	CcSEcCtD
Floxuridine—Rash—Epirubicin—pancreatic cancer	1.84e-05	0.000361	CcSEcCtD
Floxuridine—Dermatitis—Epirubicin—pancreatic cancer	1.83e-05	0.000361	CcSEcCtD
Floxuridine—Headache—Epirubicin—pancreatic cancer	1.82e-05	0.000359	CcSEcCtD
Floxuridine—TYMP—Metabolism—PIK3CG—pancreatic cancer	1.78e-05	0.000847	CbGpPWpGaD
Floxuridine—Nausea—Epirubicin—pancreatic cancer	1.73e-05	0.00034	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—CDKN2A—pancreatic cancer	1.72e-05	0.000819	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PPARG—pancreatic cancer	1.72e-05	0.000817	CbGpPWpGaD
Floxuridine—Vomiting—Doxorubicin—pancreatic cancer	1.71e-05	0.000337	CcSEcCtD
Floxuridine—Rash—Doxorubicin—pancreatic cancer	1.7e-05	0.000334	CcSEcCtD
Floxuridine—Dermatitis—Doxorubicin—pancreatic cancer	1.7e-05	0.000334	CcSEcCtD
Floxuridine—Headache—Doxorubicin—pancreatic cancer	1.69e-05	0.000332	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—CCND1—pancreatic cancer	1.63e-05	0.000773	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CD44—pancreatic cancer	1.6e-05	0.000761	CbGpPWpGaD
Floxuridine—Nausea—Doxorubicin—pancreatic cancer	1.6e-05	0.000315	CcSEcCtD
Floxuridine—TYMP—Metabolism—PIK3CD—pancreatic cancer	1.57e-05	0.000744	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GCG—pancreatic cancer	1.54e-05	0.00073	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CCND1—pancreatic cancer	1.46e-05	0.000692	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—STK11—pancreatic cancer	1.45e-05	0.000686	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CB—pancreatic cancer	1.37e-05	0.000649	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTGS2—pancreatic cancer	1.35e-05	0.000643	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MYC—pancreatic cancer	1.31e-05	0.00062	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTEN—pancreatic cancer	1.18e-05	0.000561	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MYC—pancreatic cancer	1.17e-05	0.000555	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—APOE—pancreatic cancer	1.01e-05	0.00048	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TP53—pancreatic cancer	9.6e-06	0.000456	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CG—pancreatic cancer	9.12e-06	0.000433	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PPARG—pancreatic cancer	8.81e-06	0.000418	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CA—pancreatic cancer	8.33e-06	0.000395	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CD—pancreatic cancer	8.02e-06	0.000381	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CB—pancreatic cancer	6.99e-06	0.000332	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTGS2—pancreatic cancer	6.93e-06	0.000329	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—AKT1—pancreatic cancer	6.81e-06	0.000323	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTEN—pancreatic cancer	6.04e-06	0.000287	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CA—pancreatic cancer	4.26e-06	0.000202	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AKT1—pancreatic cancer	3.48e-06	0.000165	CbGpPWpGaD
